Malonyl-CoA-acyl carrier protein transacylase (MCAT) is an enzyme involved in mito-chondrial fatty acid synthesis (mtFAS) and catalyzes the transfer of the malonyl moiety of malo-nyl-CoA to the mitochondrial acyl carrier protein (ACP). Previously, we showed that loss-of-function of mtFAS genes, including Mcat, is associated with severe loss of electron transport chain (ETC) complexes in mouse immortalized skeletal myoblasts (Nowinski et al., 2020). Here, we report a proband presenting with hypotonia, failure to thrive, nystagmus, and abnormal brain MRI findings. Using whole exome sequencing, we identified biallelic variants in MCAT. Protein levels for NDUFB8 and COXII, subunits of complex I and IV respectively, were markedly reduced in lymphoblasts and fibroblasts, as well as SDHB for complex II in fibroblasts. ETC enzyme activities were decreased in parallel. Re-expression of wild-type MCAT rescued the phenotype in patient fibroblasts. This is the first report of a patient with MCAT pathogenic variants and combined oxidative phosphorylation deficiency.

Original languageEnglish
Article numbere68047
StatePublished - Mar 2023


Dive into the research topics of 'Recessive pathogenic variants in MCAT cause combined oxidative phosphorylation deficiency'. Together they form a unique fingerprint.

Cite this